127 related articles for article (PubMed ID: 567297)
1. Cell-mediated immunity to measles, myelin basic protein, and central nervous system extract in multiple sclerosis. A longitudinal study employing direct buffy coat migration inhibition assays.
Lisak RP; Zweiman B; Waters D; Korpowski H; Pleasure DE
Neurology; 1978 Aug; 28(8):798-803. PubMed ID: 567297
[TBL] [Abstract][Full Text] [Related]
2. In vitro cellular responsiveness in multiple sclerosis patients to a purified measles virus nuclear core and to other viral antigens.
Ciongoli AK; Lisak RP; Zweiman B; Koprowski H; Waters D
J Neurol Sci; 1976 Jul; 28(3):331-8. PubMed ID: 932780
[TBL] [Abstract][Full Text] [Related]
3. Direct leukocyte migration inhibition by myelin basic protein in exacerbations of multiple sclerosis.
Sheremata W; Triller H; Cosgrove JB; Eylar EH
Can Med Assoc J; 1977 May; 116(9):985-8. PubMed ID: 870161
[TBL] [Abstract][Full Text] [Related]
4. Subacute sclerosing panencephalitis and multiple sclerosis: in vitro measles immunity and sensitization to myelin basic protein.
Sheremata W; Sazant A; Watters G
Can Med Assoc J; 1978 Mar; 118(5):509-13. PubMed ID: 343902
[TBL] [Abstract][Full Text] [Related]
5. [State of measles immunity in mulitple sclerosis].
Atanadze SN
Vopr Virusol; 1978; (3):259-67. PubMed ID: 695518
[No Abstract] [Full Text] [Related]
6. Measles virus-induced migration inhibition in vitro of leukocytes from patients with multiple sclerosis.
Nordal HJ; Froland SS; Vandvik B; Norrby E
Scand J Immunol; 1976; 5(5):587-91. PubMed ID: 959780
[TBL] [Abstract][Full Text] [Related]
7. Letter: Suppressed cellular immunity to measles antigen in multiple-sclerosis patients.
Utermohlen V; Zabriskie JB
Lancet; 1973 Nov; 2(7838):1147-8. PubMed ID: 4128034
[No Abstract] [Full Text] [Related]
8. A suppression of cellular immunity in patients with multiple sclerosis.
Utermohlen V; Zabriskie JB
J Exp Med; 1973 Dec; 138(6):1591-6. PubMed ID: 4357685
[No Abstract] [Full Text] [Related]
9. Cellular immunity to encephalitogenic protein in multiple sclerosis. Correlations with other laboratory characteristics at different disease courses.
Nilsson O; Thelin C
Eur Neurol; 1977; 16(1-6):247-56. PubMed ID: 79488
[TBL] [Abstract][Full Text] [Related]
10. [Measles cellular immunity in patients with multiple sclerosis].
Atanadze SN; Kodkind GKh; Smirnov YuK ; Khomak VIa; Veĭn AM
Vopr Virusol; 1980; (2):166-9. PubMed ID: 6992452
[TBL] [Abstract][Full Text] [Related]
11. Measles virus-induced migration inhibition of human leukocytes in vitro: an expression of cell-mediated immunity?
Nordal HJ; Froland SS; Vandvik B; Norrby E
Scand J Immunol; 1976; 5(8):969-77. PubMed ID: 996451
[TBL] [Abstract][Full Text] [Related]
12. Studies on the immune response in multiple sclerosis and other inflammatory diseases of the central nervous system.
Kinnman J
Acta Neurol Scand Suppl; 1981; 81():1-96. PubMed ID: 6939210
[No Abstract] [Full Text] [Related]
13. Cellular hypersensitivity in attacks of multiple sclerosis. I. A comparative study of migration inhibitory factor production and lymphoblastic transformation in response to myelin basic protein in multiple sclerosis.
Colby SP; Sheremata W; Bain B; Eylar EH
Neurology; 1977 Feb; 27(2):132-9. PubMed ID: 556829
[TBL] [Abstract][Full Text] [Related]
14. Changes in immune response during responses in MS patients.
Detels R; Myers LW; Ellison GW; Visscher BR; Malmgren RM; Madden DL; Sever JL
Neurology; 1981 Apr; 31(4):492-5. PubMed ID: 6452588
[TBL] [Abstract][Full Text] [Related]
15. Multiple sclerosis: sensitization of a myelin basic protein fragment (peptide T) encephalitogenic to primates. A preliminary report.
Sheremata W; Eylar EH; Cosgrove JB
J Neurol Sci; 1977 Jun; 32(2):255-63. PubMed ID: 69018
[TBL] [Abstract][Full Text] [Related]
16. The etiology and pathogenesis of multiple sclerosis: recent developments.
Raine CS
Pathobiol Annu; 1977; 7():347-84. PubMed ID: 339153
[No Abstract] [Full Text] [Related]
17. Immune reactivity to brain and viral antigens in multiple sclerosis patients: detection by the leucocyte adherence inhibition assay.
Mayer M; Opavský J; Bártová A
Acta Univ Palacki Olomuc Fac Med; 1984; 107():277-83. PubMed ID: 6085908
[No Abstract] [Full Text] [Related]
18. In vitro cellular responsiveness in multiple sclerosis patients to a viral isolate from multiple sclerosis brain tissue and to other antigens.
Ciongoli AK; Lisak RP; Zweiman B; Koprowski H; Waters D
Neurology; 1975 Sep; 25(9):891-3. PubMed ID: 169493
[TBL] [Abstract][Full Text] [Related]
19. Letter: Cellular immunity in multiple sclerosis.
Fuccillo DA; Abela JE; Traub RG; Gillespie MM; Beadle EL; Sever JL
Lancet; 1975 Apr; 1(7913):980. PubMed ID: 48155
[No Abstract] [Full Text] [Related]
20. Cell mediated immunity to viral antigens in multiple sclerosis.
Zabriskie JB; Espinoza LR; Plank CR; Collins RC
Acta Neurol Scand Suppl; 1977; 63():239-51. PubMed ID: 265669
[No Abstract] [Full Text] [Related]
[Next] [New Search]
